PPARG and metabolic dysfunction-associated steatotic liver disease: PPAR-γ evokes β-oxidation of fatty acids, increasing glucose uptake and catabolism, and in turn, alleviates non-alcoholic fatty liver disease (NALFD) and improves IR.